INTERNATIONAL CONGRESS OF
PharmacoGenetics
Recent Progress in Glioblastoma Targeted Therapy via Smart Nanoparticle Delivery Systems
-
Habib Ghaznavi,1 Saman Sargazi,2 Milad Shirvaliloo,3 Roghayeh Sheervalilou,4,*
1. Zahedan University of Medical Sciences
2. Zahedan University of Medical Sciences
3. Tabriz University of Medical Sciences
4. Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
- Introduction: The burgeoning field of nanobiomedicine, by integrating nanotechnology with biomedical research, offers revolutionary diagnostic and therapeutic solutions for cancer, especially in theranostics.
- Methods: This review specifically examines the latest progress in targeted glioblastoma therapy, highlighting the application of inorganic smart nanoparticles.
- Results: It delves into their groundbreaking use in glioblastoma treatment, supported by evidence from in vitro studies, in vivo investigations, and ongoing clinical trials, extending beyond the general medical utility of nanotechnology.
- Conclusion: Nanobiomedicine, the convergence of nanotechnology and biomedical research, is poised to revolutionize cancer diagnosis and treatment, particularly via theranostic.
- Keywords: Glioblastoma, Targeted Therapy, Smart Nanoparticle, Delivery Systems
